Dermagenix Lab continues to push the boundaries of skincare innovation. A recent clinical study, highlighted the excellent safety profile of its signature products, Step 1: Non Surgical Eye Lift Solution and Step 2: Intensive Eye Serum, known for reducing fine lines and wrinkles. Conducted by Princeton Consumer Research, the study reported zero adverse reactions, irritations, or sensitizations among over 100 neutral participants. These findings emphasize Dermagenix Lab's dedication to delivering safe, effective, and gentle skincare solutions, backed by rigorous clinical validation for consumer confidence.
Beginning on August 7th, 2023, and concluding on September 18th, 2023, Princeton Consumer Research Corp conducted a thorough evaluation of the safety of Dermagenix Lab products. Led by Principal Investigator B.D. and Study Supervisor A.K., they ensured compliance with strict protocols and authorization standards. The study adhered to ICH Good Clinical Practice guidelines, confirming that Dermagenix Lab's skincare products met rigorous safety and quality standards. Their dedication ensured that the products underwent careful oversight, further solidifying their safety profile for consumer use.
TABLE
According to the final report, drafted on October 5th, 2023, "These results support the conclusion that under the conditions of the study, the test products demonstrated a low potential for irritation and sensitization." A total of nine occlusive patches were worn carefully for 2-3 days over a span of three weeks, with assessments made 1 hour and 48 hours after removal. This approach was chosen to mimic real-world product use, ensuring the study's findings are directly applicable to everyday consumer experiences.
